"F.D.A. Approves Alzheimer's Drug Despite Fierce Debate Over Whether It Works" That's how The New York Times headlined its story about the FDA's accelerated approval of Biogen's drug aducanumab, which will go by the brand
Drug Discovery Industry Roundup with Barry Bunin — June 9, 2021 Drug Discovery Industry Roundup with Barry Bunin — June 9, 2021 Barry Bunin, PhDFounder & CEOCollaborative Drug Discovery “F.D.A. Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works” That’s how The New York Times headlined its story about the FDA’s accelerated approval of Biogen’s drug aducanumab, which will go by the brand name Aduhelm.… The post Drug Discovery Industry Roundup with Barry Bunin — June 9, 2021 appeared first on Collaborative Drug Discovery Inc. (CDD). by Abe Wang, CDD Webpage: https://ift.tt/3w8JHF9 Bengaluru: June 09, 2021 at 11:27PM |
Zastra's JournalArchives
April 2023
Categories |